News
News Medical on MSN
CRISPR’s Efficiency Triples with Spherical Nucleic Acid Delivery System
The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.
Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...
Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global CRISPR-based gene editing market size was estimated at USD 3.06 billion in 2024. It is predicted to surpass ...
Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.
Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...
Morning Overview on MSN
CyDENT: CRISPR‑free base editing for mitochondria and chloroplasts
CyDENT represents a revolutionary advancement in genetic modification, facilitating CRISPR-free base editing within ...
Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...
The type I CRISPR protein Cas3 works like Pac-Man, chomping away at a continuous stream of nucleotides with intrinsic activity for introducing targeted large deletions from a few hundred base pairs to ...
This article was written for our sponsor, Innovation Road Trip. Eradication of certain diseases, increasing crop sizes, reducing pest populations — the current and future applications of CRISPR have ...
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...
BUFFALO, NY- November 28, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on November 27, 2023, entitled, “The double-edge sword of CRISPR application for in vivo studies.” In ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results